Illumina INC whole genome sequencing kits
Ended Awarded Last action
- Contract number
- 75N95020F00004
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $496,847
Award facts
- Contract value 100% obligated
- $496,846.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$415 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $497,262 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents, a $496,846.73 firm fixed price delivery order contract for whole genome sequencing kits. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing products and services to support the agency's genomics research and diagnostic initiatives. Illumina has previously held prime contracts and subcontracts with various federal agencies, including the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Department of Agriculture, to supply a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems and related consumables, as well as bioinformatics support. This award appears to be part of Illumina's existing Indefinite Delivery Contract worth up to $3.3 million with the Department of the Navy Bureau of Medicine and Surgery, which provides sequencing platforms and reagents for use in the Naval Medical Research Center's biological threat characterization efforts.
Quick answers
Who was awarded contract 75N95020F00004?
75N95020F00004 was awarded to Illumina, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 23, 2020.
How much is contract 75N95020F00004 worth?
The government has obligated $496,847 on 75N95020F00004.
Which agency awarded contract 75N95020F00004?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00004, with funding from National Institute on Aging (National Institutes of Health).
Is contract 75N95020F00004 an order under another contract?
Yes. 75N95020F00004 is a delivery order under HHSN268201500004I, an indefinite delivery contract.
Was contract 75N95020F00004 competed?
The extent of competition for 75N95020F00004 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award